Mineralys Therapeutics, Inc. (MLYS)
35.95
-0.95
(-2.57%)
USD |
NASDAQ |
Dec 15, 15:28
Mineralys Therapeutics EPS Diluted (Quarterly): -0.5232 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Liquidia Corp. | -0.0409 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Arrowhead Pharmaceuticals, Inc. | -0.175 |
| Insmed, Inc. | -1.747 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.93M |
| Total Expenses (Quarterly) | 36.93M |
| Enterprise Value | 2.327B |
| Earnings Yield | -8.23% |
| Normalized Earnings Yield | -8.228 |